Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Histamine-3 receptor antagonists

Histamine-3 receptor antagonists

US Patent 8158673 · Granted Apr 17, 2012

Estimated economic value: $210,372,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Tricyclic compounds and their use as phosphodiesterase inhibitors2022
Tricyclic compounds and their use as phosphodiesterase inhibitors2022
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors2022
Cyclic substituted imidazo[4,5-c]quinoline derivatives2021
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds2020
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands2020
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds2019
Pyrazolopyrimidine compounds2018
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2018